By Katherine Hobson
Generics are king.
That’s the message from the latest report on U.S. medication use by the IMS Institute for Healthcare Informatics, which found that non-branded drugs now make up 78% of all prescriptions dispensed.
There are only three name-brand drugs on the list of the most commonly prescribed medications: Pfizer’s Lipitor, at #12; Sanofi-Aventis’s and Bristol-Myers Squibb’s Plavix, at #23 and Merck’s Singulair, at #25. And all three are due to lose patent protection this year or next. (The report also says that within 6 months of patent loss, generics take 80% of prescription share.)
The year’s runaway favorite drug was, once again, hydrocodone/acetaminophen, the generic form of the painkiller Vicodin. More than 131 million prescriptions were dispensed last year, about 37 million more than the second-most popular drug, the generic anti-cholesterol drug simvastatin.
The list of top-selling drugs by dollars, of course, is made up entirely of brand-name drugs, with Lipitor, AstraZeneca’s Nexium, Plavix, GlaxoSmithKline’s Advair Diskus and Bristol-Myers’s and Otsuka America’s Abilify as Nos. 1-5. (Forbes’s Matthew Herper wonders how Nexium, “the poster child for me-too medicines,” managed to generate $6.3 billion in sales.)
Overall, spending on medicines rose to more than $307 billion, up just 2.3%. Here’s the Dow Jones Newswires story about the report.
Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.” Email: jackfriday2011(at)hotmail.co.uk
Wednesday, April 20, 2011
What Drug Did Doctors Prescribe Most Last Year? - Health Blog - WSJ
via blogs.wsj.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment